#1. Snigdha S, Ha K, Tsai P, et al. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan. Pharmacol Ther. 2022 Mar;231:107978.
#2. Sanders ME, Merenstein DJ, Reid G, et al. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):605-16.
#3. Siddiqui R, Makhlouf Z, Alharbi AM, et al. The Gut Microbiome and Female Health. Biology (Basel). 2022 Nov 21;11(11):1683.
#4. Del’arco APWT, Magalhães P, Quilici FA. SIM Brasil Study – Women’s gastrointestinal health: gastrointestinal symptoms and impact on the Brazilian women quality of life. Arq Gastroenterol. 2017 Apr-Jun;54(2):115-22.
#5. Barrea L, Verde L, Auriemma RS, et al. Probiotics and Prebiotics: Any Role in Menopause-Related Diseases? Curr Nutr Rep. 2023 Mar;12(1):83-97.
#6. Ghosh TS, Shanahan F, O’Toole PW. The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol. 2022 Sep;19(9):565-84.
#7. Peters BA, Santoro N, Kaplan RC, Qi Q. Spotlight on the Gut Microbiome in Menopause: Current Insights. Int J Womens Health. 2022 Aug 10;14:1059-72.
#8. Mei Z, Li D. The role of probiotics in vaginal health. Front Cell Infect Microbiol. 2022 Jul 28;12:963868.
#9. Margolis KG, Cryan JF, Mayer EA. The Microbiota-Gut-Brain Axis: From Motility to Mood. Gastroenterology. 2021 Apr;160(5):1486-501.
#10. Wickens KL, Barthow CA, Murphy R, et al. Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial. Br J Nutr. 2017;117(6):804-13.
#11. Schmidt EB, Piccoloto NM, Müller MC. Depressão pós-parto: fatores de risco e repercussões no desenvolvimento infantil. Psico-USF [Internet]. 2005Jun;10(1):61–8.
#12. Song J, Zhou B, Kan J, et al. Gut microbiota: Linking nutrition and perinatal depression. Front Cell Infect Microbiol. 2022 Aug 26;12:932309.
#13. Slykerman RF, Hood F, Wickens K, et al.; Probiotic in Pregnancy Study Group. Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial. EBioMedicine. 2017 Oct;24:159-65.
#14. Wickens K, Stanley TV, Mitchell EA, et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy. 2013 Sep;43(9):1048-57.
#15. Wickens K, Black PN, Stanley TV, et al.; Probiotic Study Group. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008 Oct;122(4):788-794.
#16. Wickens K, Black P, Stanley TV, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy. 2012 Jul;42(7):1071-9.
#17. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14.
